<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37566088</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>15</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle><i>C9orf72</i> Toxic Species Affect ArfGAP-1 Function.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2007</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12152007</ELocationID><Abstract><AbstractText>Compelling evidence indicates that defects in nucleocytoplasmic transport contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS). In particular, hexanucleotide (G4C2) repeat expansions in <i>C9orf72</i>, the most common cause of genetic ALS, have a widespread impact on the transport machinery that regulates the nucleocytoplasmic distribution of proteins and RNAs. We previously reported that the expression of G4C2 hexanucleotide repeats in cultured human and mouse cells caused a marked accumulation of poly(A) mRNAs in the cell nuclei. To further characterize the process, we set out to systematically identify the specific mRNAs that are altered in their nucleocytoplasmic distribution in the presence of <i>C9orf72</i>-ALS RNA repeats. Interestingly, pathway analysis showed that the mRNAs involved in membrane trafficking are particularly enriched among the identified mRNAs. Most importantly, functional studies in cultured cells and <i>Drosophila</i> indicated that <i>C9orf72</i> toxic species affect the membrane trafficking route regulated by ADP-Ribosylation Factor 1 GTPase Activating Protein (ArfGAP-1), which exerts its GTPase-activating function on the small GTPase ADP-ribosylation factor 1 to dissociate coat proteins from Golgi-derived vesicles. We demonstrate that the function of ArfGAP-1 is specifically affected by expanded <i>C9orf72</i> RNA repeats, as well as by <i>C9orf72</i>-related dipeptide repeat proteins (C9-DPRs), indicating the retrograde Golgi-to-ER vesicle-mediated transport as a target of <i>C9orf72</i> toxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Simona</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5038-0767</Identifier><AffiliationInfo><Affiliation>Institute of Translational Pharmacology (IFT), National Research Council (CNR), 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione Santa Lucia IRCCS, c/o CERC, 00143 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Salvio</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bal&#xec;</LastName><ForeName>Marilisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology, University of Rome "La Sapienza", 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Simone</LastName><ForeName>Assia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnology, University of Rome "La Sapienza", 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apolloni</LastName><ForeName>Savina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5782-1665</Identifier><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ambrosi</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6646-7653</Identifier><AffiliationInfo><Affiliation>Fondazione Santa Lucia IRCCS, c/o CERC, 00143 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arisi</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Translational Pharmacology (IFT), National Research Council (CNR), 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Brain Research Institute "Rita Levi-Montalcini", 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cipressa</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9919-5295</Identifier><AffiliationInfo><Affiliation>Department of Ecological and Biological Science, University of Tuscia, 01100 Viterbo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzolino</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0342-8961</Identifier><AffiliationInfo><Affiliation>Institute of Translational Pharmacology (IFT), National Research Council (CNR), 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cestra</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione Santa Lucia IRCCS, c/o CERC, 00143 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology and Biotechnology, University of Rome "La Sapienza", 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020823">ADP-Ribosylation Factor 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C503237">ARFGAP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020690">GTPase-Activating Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020823" MajorTopicYN="N">ADP-Ribosylation Factor 1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="Y">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020690" MajorTopicYN="Y">GTPase-Activating Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ArfGAP-1</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Drosophila melanogaster</Keyword><Keyword MajorTopicYN="N">Golgi-to-ER trafficking</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37566088</ArticleId><ArticleId IdType="pmc">PMC10416972</ArticleId><ArticleId IdType="doi">10.3390/cells12152007</ArticleId><ArticleId IdType="pii">cells12152007</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeyers J., Banchi E.G., Latouche M. C9ORF72: What It Is, What It Does, and Why It Matters. Front. Cell. Neurosci. 2021;15:661447. doi: 10.3389/fncel.2021.661447.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.661447</ArticleId><ArticleId IdType="pmc">PMC8131521</ArticleId><ArticleId IdType="pubmed">34025358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X., Toro A., Sahana T.G., Gao J., Chalk J., Oskarsson B.E., Zhang K. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD. Mol. Neurodegener. 2020;15:34. doi: 10.1186/s13024-020-00383-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00383-7</ArticleId><ArticleId IdType="pmc">PMC7282082</ArticleId><ArticleId IdType="pubmed">32513219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C., Khalil B., Smith C.L., Rossoll W. Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol. Dis. 2020;140:104835. doi: 10.1016/j.nbd.2020.104835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Serrano A., Gerbino V., Giorgi A., Di Francesco L., Nencini M., Bozzo F., Schinina M.E., Bagni C., Cestra G., et al. Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS. J. Cell Sci. 2015;128:1787&#x2013;1799. doi: 10.1242/jcs.165332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.165332</ArticleId><ArticleId IdType="pubmed">25788698</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.H., Zhang P., Kim H.J., Mitrea D.M., Sarkar M., Freibaum B.D., Cika J., Coughlin M., Messing J., Molliex A., et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell. 2016;167:774&#x2013;788.e17. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Rompietti V., Antonucci Y., Giovannini D., Scopa C., Scaricamazza S., Scardigli R., Cestra G., Serafino A., Carri M.T., et al. UsnRNP trafficking is regulated by stress granules and compromised by mutant ALS proteins. Neurobiol. Dis. 2020;138:104792. doi: 10.1016/j.nbd.2020.104792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104792</ArticleId><ArticleId IdType="pubmed">32027933</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., Coyne A.N., Ruan K., Grima J.C., Bowen K.E., Wadhwa H., Yang P., Rigo F., et al. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell. 2018;173:958&#x2013;971.e17. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Jutzi D., Campagne S., Schmidt R., Reber S., Mechtersheimer J., Gypas F., Schweingruber C., Colombo M., von Schroetter C., Loughlin F.E., et al. Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis. Nat. Commun. 2020;11:6341. doi: 10.1038/s41467-020-20191-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20191-3</ArticleId><ArticleId IdType="pmc">PMC7733473</ArticleId><ArticleId IdType="pubmed">33311468</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck R., Rawet M., Wieland F.T., Cassel D. The COPI system: Molecular mechanisms and function. FEBS Lett. 2009;583:2701&#x2013;2709. doi: 10.1016/j.febslet.2009.07.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.07.032</ArticleId><ArticleId IdType="pubmed">19631211</ArticleId></ArticleIdList></Reference><Reference><Citation>Sztul E., Chen P.W., Casanova J.E., Cherfils J., Dacks J.B., Lambright D.G., Lee F.S., Randazzo P.A., Santy L.C., Schurmann A., et al. ARF GTPases and their GEFs and GAPs: Concepts and challenges. Mol. Biol. Cell. 2019;30:1249&#x2013;1271. doi: 10.1091/mbc.E18-12-0820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E18-12-0820</ArticleId><ArticleId IdType="pmc">PMC6724607</ArticleId><ArticleId IdType="pubmed">31084567</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M.Y., Fromm S.A., Zoncu R., Hurley J.H. Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD. Nature. 2020;585:251&#x2013;255. doi: 10.1038/s41586-020-2633-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2633-x</ArticleId><ArticleId IdType="pmc">PMC8054479</ArticleId><ArticleId IdType="pubmed">32848248</ArticleId></ArticleIdList></Reference><Reference><Citation>Su M.Y., Fromm S.A., Remis J., Toso D.B., Hurley J.H. Structural basis for the ARF GAP activity and specificity of the C9orf72 complex. Nat. Commun. 2021;12:3786. doi: 10.1038/s41467-021-24081-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24081-0</ArticleId><ArticleId IdType="pmc">PMC8213707</ArticleId><ArticleId IdType="pubmed">34145292</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristofani R., Crippa V., Vezzoli G., Rusmini P., Galbiati M., Cicardi M.E., Meroni M., Ferrari V., Tedesco B., Piccolella M., et al. The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases. Cell Stress Chaperones. 2018;23:1&#x2013;12. doi: 10.1007/s12192-017-0806-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-017-0806-9</ArticleId><ArticleId IdType="pmc">PMC5741577</ArticleId><ArticleId IdType="pubmed">28608264</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzi F., Del Fabbro C., Tomescu A.I., Policriti A. rNA: A fast and accurate short reads numerical aligner. Bioinformatics. 2012;28:123&#x2013;124. doi: 10.1093/bioinformatics/btr617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr617</ArticleId><ArticleId IdType="pubmed">22084252</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertea M., Pertea G.M., Antonescu C.M., Chang T.C., Mendell J.T., Salzberg S.L. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 2015;33:290&#x2013;295. doi: 10.1038/nbt.3122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3122</ArticleId><ArticleId IdType="pmc">PMC4643835</ArticleId><ArticleId IdType="pubmed">25690850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Wang S., Li W. RSeQC: Quality control of RNA-seq experiments. Bioinformatics. 2012;28:2184&#x2013;2185. doi: 10.1093/bioinformatics/bts356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts356</ArticleId><ArticleId IdType="pubmed">22743226</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseka P., Pathan M., Chitti S.V., Kang T., Mathivanan S. FunRich enables enrichment analysis of OMICs datasets. J. Mol. Biol. 2021;433:166747. doi: 10.1016/j.jmb.2020.166747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.166747</ArticleId><ArticleId IdType="pubmed">33310018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M.V., Jones M.R., Rouillard A.D., Fernandez N.F., Duan Q., Wang Z., Koplev S., Jenkins S.L., Jagodnik K.M., Lachmann A., et al. Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90&#x2013;W97. doi: 10.1093/nar/gkw377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Halloran M., Ragagnin A.M.G., Vidal M., Parakh S., Yang S., Heng B., Grima N., Shahheydari H., Soo K.Y., Blair I., et al. Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress. Cell. Mol. Life Sci. CMLS. 2020;77:3859&#x2013;3873. doi: 10.1007/s00018-019-03394-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03394-w</ArticleId><ArticleId IdType="pubmed">31802140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacino J.S., Hierro A. Transport according to GARP: Receiving retrograde cargo at the trans-Golgi network. Trends Cell Biol. 2011;21:159&#x2013;167. doi: 10.1016/j.tcb.2010.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2010.11.003</ArticleId><ArticleId IdType="pmc">PMC3073588</ArticleId><ArticleId IdType="pubmed">21183348</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Taylor J.P. The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD. Front. Mol. Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Gronke S., Niccoli T., Ridler C.E., Clayton E.L., Devoy A., Moens T., Norona F.E., Woollacott I.O., Pietrzyk J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M., Moulton M.J., Lu S., Bellen H.J. &#x2018;Fly-ing&#x2019; from rare to common neurodegenerative disease mechanisms. Trends Genet. TIG. 2022;38:972&#x2013;984. doi: 10.1016/j.tig.2022.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2022.03.018</ArticleId><ArticleId IdType="pmc">PMC9378361</ArticleId><ArticleId IdType="pubmed">35484057</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer J., Wang Q., Le T., Pizzo L., Gronke S., Ambegaokar S.S., Imai Y., Srivastava A., Troisi B.L., Mardon G., et al. Quantitative Assessment of Eye Phenotypes for Functional Genetic Studies Using Drosophila melanogaster. G3 (Bethesda) 2016;6:1427&#x2013;1437. doi: 10.1534/g3.116.027060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/g3.116.027060</ArticleId><ArticleId IdType="pmc">PMC4856093</ArticleId><ArticleId IdType="pubmed">26994292</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A., Mertens J., Boeynaems S., Bogaert E., Chai N., Yamada S.B., Paul Iii J.W., Sun S., Herdy J.R., Bieri G., et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Culjkovic-Kraljacic B., Borden K.L. Aiding and abetting cancer: mRNA export and the nuclear pore. Trends Cell Biol. 2013;23:328&#x2013;335. doi: 10.1016/j.tcb.2013.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2013.03.004</ArticleId><ArticleId IdType="pmc">PMC3700650</ArticleId><ArticleId IdType="pubmed">23582887</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Hou S., Chen M., Lei H. Mechanisms of RNA export and nuclear retention. Wiley Interdiscip. Rev. RNA. 2023;14:e1755. doi: 10.1002/wrna.1755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1755</ArticleId><ArticleId IdType="pubmed">35978483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziff O.J., Harley J., Wang Y., Neeves J., Tyzack G., Ibrahim F., Skehel M., Chakrabarti A.M., Kelly G., Patani R. Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is restored by VCP ATPase inhibition. Neuron. 2023;111:1&#x2013;17. doi: 10.1016/j.neuron.2023.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.06.019</ArticleId><ArticleId IdType="pubmed">37480846</ArticleId></ArticleIdList></Reference><Reference><Citation>Asp L., Kartberg F., Fernandez-Rodriguez J., Smedh M., Elsner M., Laporte F., Barcena M., Jansen K.A., Valentijn J.A., Koster A.J., et al. Early stages of Golgi vesicle and tubule formation require diacylglycerol. Mol. Biol. Cell. 2009;20:780&#x2013;790. doi: 10.1091/mbc.e08-03-0256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-03-0256</ArticleId><ArticleId IdType="pmc">PMC2633395</ArticleId><ArticleId IdType="pubmed">19037109</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V., Sultana J.M., Atkin J.D. Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences. Front. Neurosci. 2015;9:400. doi: 10.3389/fnins.2015.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00400</ArticleId><ArticleId IdType="pmc">PMC4621950</ArticleId><ArticleId IdType="pubmed">26578862</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase G., Rabouille C. Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles. Front. Neurosci. 2015;9:448. doi: 10.3389/fnins.2015.00448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00448</ArticleId><ArticleId IdType="pmc">PMC4672084</ArticleId><ArticleId IdType="pubmed">26696811</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson D.W., Baker M.C., Jackson J.L., DeJesus-Hernandez M., Finch N.A., Tian S., Heckman M.G., Pottier C., Gendron T.F., Murray M.E., et al. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. Acta Neuropathol. Commun. 2019;7:150. doi: 10.1186/s40478-019-0797-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0797-0</ArticleId><ArticleId IdType="pmc">PMC6781370</ArticleId><ArticleId IdType="pubmed">31594549</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>